Skip to main content

Home/ WSU BIOL209 Microbiology/ Group items tagged epidemiology

Rss Feed Group items tagged

Casey Finnerty

New Technologies in Clinical Microbiology - 0 views

  • Unfortunately, when laboratory methods rely solely on cultivation of pathogens and traditional phenotypic methods of pathogen characterization, physicians are forced to deduce the presence of BSI based on clinical symptoms, which are often nonspecific. Subsequently, antibiotic therapy is initiated based on clinical and epidemiologic profiles (28) rather than on laboratory evidence. Typically, within 1 to 3 days a microscopic Gram stain category (Gram-positive bacteria, Gram-negative bacteria, or fungi) provides physicians with a general direction for antibiotic therapy. Definitive results that eliminate the need for broad-spectrum therapy and enable de-escalation and the tailoring of treatment to the most effective antibiotic regimen often require more than 3 to 5 days. This gap has been implicated as one reason for high mortality and the emergence of drug-resistant microbes.
    • Casey Finnerty
       
      Alison, I found this reference after our chat today at the end of the lab. I think you would find this paper very interesting.
  •  
    This paper is an excellent review on the need for improved protocols for microbial identification the technologies that are under development.
Amy Jorgenson

Coccidioidomycosis-A Fungal Disease of the Americas - 0 views

  •  
    This paper is an overview of Coccidioidomycosis. The explains the demographics, the life cycle, history, immunology, and treatment. The hope for a vaccine is also prevalent in this paper.  The paper summarizes Coccidioidomycosis and gives quick details about it.  Excellent paper on learning about the disease without diving in too deeply.
  •  
    This article discusses the etiology and epidemiology of coccidiodiomycosis as well as the potential for a vaccine to treat the devastating symptoms brought about by this disease.
Casey Finnerty

Reassessing Flu Shots as the Season Draws Near - NYTimes.com - 0 views

  • “It does not protect as promoted. It’s all a sales job: it’s all public relations.”
  • “I say, ‘Use this vaccine,’ ” he said. “The safety profile is actually quite good. But we have oversold it. Use it — but just know it’s not going to work nearly as well as everyone says.”
  • “Does it work as well as the measles vaccine? No, and it’s not likely to. But the vaccine works,” Dr. Joseph Bresee, chief of epidemiology and prevention in the C.D.C.’s influenza division, said. And research is advancing to improve the effectiveness of the vaccine.
  • ...2 more annotations...
  • “Not having evidence doesn’t prove it doesn’t work; we just don’t know,” said Dr. Roger Thomas, a Cochrane Collaboration coordinator for the University of Calgary in Alberta, who was an author of both of the reviews. “The intelligent decision would be to have large, publicly funded independent trials.”
  • Another option for those who want to reduce their risk of influenza and flulike infections may be simply this: Wash your hands more often. There is good evidence this works.
Casey Finnerty

Which Countries Could Become Disease Hot Spots? - 0 views

  • The six least-vulnerable countries include all four Scandinavian countries, Germany, and Canada.
1 - 7 of 7
Showing 20 items per page